ABSTRACT Bacillus coagulans ZB29, isolated from milk, is a safe strain already available on market shelves and characterized by certified beneficial effects. Here, we report the 3,646,473-bp genome sequence of this bacterium, its sequence assembly, and its annotations.
ZB29 and combat intestinal infections caused by drug-resistant pathogenic bacteria. The relevance of these genes in the draft genome validates the potential of ZB29 as a probiotic. In addition, this genome harbors 2 CRISPR arrays, which were further confirmed using CRISPRFinder (5) .
However, exploring the genome of B. coagulans ZB29 to unveil the genetic determinants of safety and probiosis toward emerging challenges in commercialization still remains to be done.
Data availability. This whole-genome shotgun project has been deposited in DDBJ/EMBL/GenBank under the accession number QPFA00000000 (BioSample number SAMN09489659, BioProject number PRJNA475407, and SRA number SRR8204338). The version described in this paper is the first version (QPFA01000000).
